Urology

Tamsulosin-intraoperative floppy iris syndrome link is urged to be considered by primary care physicians

August 01, 2009

A recent article in the Journal of the American Medical Association, an editorial in American Family Physician, articles in the general media outlets, and an updated patient advisory statement from the American Society of Cataract and Refractive Surgery and the American Academy of Ophthalmology aim to further education primary care physicians and patients about the association between a patient's use of tamsulosin and complications or difficulty during cataract surgery.

Anticipate silodosin-IFIS link, surgeon says

November 05, 2008

History-taking is a little more time-consuming for cataract surgeons with the recent FDA approval of silodosin capsules (Rapaflo, Watson) for the treatment of symptoms due to benign prostatic hyperplasia.

ASCRS, AAO have new advice for primary care physicians about alpha blockers and IFIS

July 09, 2008

The American Academy of Ophthalmology and the American Society of Cataract and Refractive Surgery are working with the American College of Physicians and the American Academy of Family Physicians to educate prescribers of tamsulosin (Flomax, Boehringer Ingelheim) about the association between the use of alpha blockers and intraoperative floppy eye syndrome.

Techniques can help surgeons manage IFIS

July 01, 2007

Cataract surgeons can reduce the rate of complication from intraoperative floppy iris syndrome (IFIS) by using certain techniques before and during surgery.

Medications for ED can harm optic nerve

July 01, 2007

Increasing use of erectile dysfunction (ED) drugs has added a new topic to the ophthalmologist-patient conversation: possible risks to the optic nerve in certain patients with glaucoma who are taking ED medications.

Alternative strategies successful in managing IFIS

February 01, 2007

Las Vegas-Ophthalmologists can use one of several modified strategies to perform cataract surgery in patients who are taking or have taken tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), with good outcomes and low complication rates, when they know of the medication history in advance, David F. Chang, MD, told those attending the annual meeting of the American Academy of Ophthalmology here.

Alternative strategies successful in managing IFIS

February 01, 2007

Las Vegas-Ophthalmologists can use one of several modified strategies to perform cataract surgery in patients who are taking or have taken tamsulosin (Flomax, Boehringer Ingelheim Pharmaceuticals), with good outcomes and low complication rates, when they know of the medication history in advance, David F. Chang, MD, told those attending the annual meeting of the American Academy of Ophthalmology here.

OLA honors 2006 Awards of Excellence winners

December 15, 2006

Orlando, FL-The Optical Laboratories Association (OLA) recently presented its OLA Awards of Excellence, one of the most prestigious awards offered by the optical industry, during The OLA 2006 annual conference, Nov. 9 to 11 at the Gaylord Palms Resort and Convention Center in Orlando.

Complications take center stage in cataract surgery arena

December 01, 2006

The year 2006 may be characterized as an interesting one in cataract surgery, according to ophthalmologists who are opinion leaders in the field.

Complement molecules may lead to early AMD detection

November 01, 2006

Lexington, KY-Animal studies point to two components of drusen as the driving force for the neovascularization that causes age-related macular degeneration (AMD) -a discovery that opens the way to early detection and drug therapy to prevent the condition, said Jayakrishna Ambati, MD.

x